Founded in 2001, Rinat Neuroscience was formed when Genentech spun out its key neuroscience assets under a broad license. With over 15 years of investment in research and development, Rinat is now a pioneer in developing and commercializing antibody drugs for diseases and disorders of the nervous system. Their focus includes developing protein therapeutics for pain, Alzheimer's disease, obesity and diabetes, and neuropathies. Additionally, Rinat is working on novel disease modifying therapies that target specific populations of neurons affected in particular disease states. The company is based in South San Francisco, California.